PRESS RELEASE published on 05/10/2024 at 18:00, 1 year 10 months ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 10 months ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
BRIEF published on 05/08/2024 at 09:05, 1 year 10 months ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
BRIEF published on 05/08/2024 at 09:05, 1 year 10 months ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
PRESS RELEASE published on 05/08/2024 at 09:00, 1 year 10 months ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
PRESS RELEASE published on 05/08/2024 at 09:00, 1 year 10 months ago Informations privilégiées / Autres communiqués Medincell suspend la cotation de ses actions sur Euronext Paris, en attente de la publication d'un communiqué. Reprise des négociations prévue demain Euronext Paris Cotation Suspension Medincell Communiqué
Published on 04/01/2026 at 08:05, 1 hour 34 minutes ago Tocvan Discovers New Gold-Silver Zone 1,600 Meters From Main Zone at South Block Gran Pilar; First Aggressive Step-Out Drilling Intersects Mineralization From Surface
Published on 04/01/2026 at 08:00, 1 hour 39 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 04/01/2026 at 04:06, 5 hours 33 minutes ago Jaguar Mining Reports Financial Results for the Fourth Quarter and Full Year 2025
Published on 04/01/2026 at 03:57, 5 hours 42 minutes ago NXT Energy Solutions Announces 2025 Year-End Results
Published on 04/01/2026 at 09:05, 34 minutes ago Solar Power to Go: Jackery Unveils SolarSaga 40 Air, the Next Generation of Compact Foldable Solar Panels
Published on 04/01/2026 at 09:05, 34 minutes ago Rockwell Automation Announces ROKStudios Video Series Launches a New Season Exploring the Journey from Automation to Autonomy
Published on 04/01/2026 at 09:00, 39 minutes ago Partners Group appoints Pete Zippelius as new Co-Head of Private Equity Health & Life
Published on 04/01/2026 at 08:00, 1 hour 39 minutes ago Transfert du contrat de liquidité aupres de Natixis Oddo BHF
Published on 04/01/2026 at 08:00, 1 hour 39 minutes ago Résultats annuels 2025 - ANR par action en hausse de + 8,1 % à 97,10 € - Fonds propres consolidés : 740 M€
Published on 03/31/2026 at 20:08, 13 hours 31 minutes ago SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 14 hours 33 minutes ago SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 14 hours 33 minutes ago Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
